InspireMD Shares Outstanding History (NSPR)
InspireMD reported 43.5M shares outstanding at the end of fiscal 2025.
View full InspireMD company overviewInspireMD annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 43.5M | 16.9M | +63.59% |
| 2024 | 2024-12-31 | 26.6M | 4.8M | +21.84% |
| 2023 | 2023-12-31 | 21.8M | 13.5M | +162.17% |
| 2022 | 2022-12-31 | 8.3M | 34,662 | +0.42% |
| 2021 | 2021-12-31 | 8.3M | 5.0M | +152.60% |
| 2020 | 2020-12-31 | 3.3M | −631,812 | −16.13% |
| 2019 | 2019-12-31 | 3.9M | −34.5M | −89.80% |
| 2018 | 2018-12-31 | 38.4M | 36.9M | +2488.38% |
| 2017 | 2017-12-31 | 1.5M | 1.4M | +3378.20% |
| 2016 | 2016-12-31 | 42,653 | −271,412 | −86.42% |
| 2015 | 2015-12-31 | 314,065 | −3.8M | −92.41% |
| 2014 | 2014-12-31 | 4.1M | 738,517.4 | +21.73% |
| 2013 · Dec 31 | 2013-12-31 | 3.4M | 9,450.1 | +0.28% |
| 2013 · Jun 30 | 2013-06-30 | 3.4M | 1.7M | +98.88% |
| 2012 | 2012-06-30 | 1.7M | −469.65 | −0.03% |
| 2011 | 2011-12-31 | 1.7M | 457,878.625 | +36.73% |
| 2010 | 2010-12-31 | 1.2M | — | — |
InspireMD quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 46.9M | 14.4M | +44.14% |
| Q1 2026 | 2026-03-31 | 46.8M | 17.1M | +57.43% |
| Q4 2025 | 2025-12-31 | 43.5M | 16.9M | +63.59% |
| Q3 2025 | 2025-09-30 | 41.9M | 16.2M | +62.98% |
| Q2 2025 | 2025-06-30 | 32.6M | 7.4M | +29.20% |
| Q1 2025 | 2025-03-31 | 29.8M | 6.3M | +27.08% |
| Q4 2024 | 2024-12-31 | 26.6M | 4.8M | +21.84% |
| Q3 2024 | 2024-09-30 | 25.7M | 4.3M | +20.18% |
| Q2 2024 | 2024-06-30 | 25.2M | 4.0M | +18.90% |
| Q1 2024 | 2024-03-31 | 23.4M | 15.1M | +181.17% |
| Q4 2023 | 2023-12-31 | 21.8M | 13.5M | +162.17% |
| Q3 2023 | 2023-09-30 | 21.4M | 13.1M | +156.73% |
| Q2 2023 | 2023-06-30 | 21.2M | 12.9M | +154.62% |
| Q1 2023 | 2023-03-31 | 8.3M | 8,772 | +0.11% |
| Q4 2022 | 2022-12-31 | 8.3M | 34,662 | +0.42% |
| Q3 2022 | 2022-09-30 | 8.3M | 435,295 | +5.51% |
| Q2 2022 | 2022-06-30 | 8.3M | 408,861 | +5.17% |
| Q1 2022 | 2022-03-31 | 8.3M | 465,085 | +5.92% |
| Q4 2021 | 2021-12-31 | 8.3M | 5.0M | +152.60% |
| Q3 2021 | 2021-09-30 | 7.9M | −28.2M | −78.09% |
| Q2 2021 | 2021-06-30 | 7.9M | −25.4M | −76.28% |
| Q1 2021 | 2021-03-31 | 7.9M | 3.5M | +80.99% |
| Q4 2020 | 2020-12-31 | 3.3M | −631,812 | −16.13% |
| Q3 2020 | 2020-09-30 | 36.1M | 32.6M | +943.10% |
| Q2 2020 | 2020-06-30 | 33.4M | 32.0M | +2287.67% |
| Q1 2020 | 2020-03-31 | 4.3M | 3.5M | +397.65% |
| Q4 2019 | 2019-12-31 | 3.9M | 3.1M | +409.51% |
| Q3 2019 | 2019-09-30 | 3.5M | −33.2M | −90.58% |
| Q2 2019 | 2019-06-30 | 1.4M | −5.1M | −78.35% |
| Q1 2019 | 2019-03-31 | 871,872 | −2.6M | −75.10% |
| Q4 2018 | 2018-12-31 | 768,615 | −714,941 | −48.19% |
| Q3 2018 | 2018-09-30 | 36.7M | 29.2M | +391.49% |
| Q2 2018 | 2018-06-30 | 6.5M | −1.0M | −13.58% |
| Q1 2018 | 2018-03-31 | 3.5M | −3.3M | −48.74% |
| Q4 2017 | 2017-12-31 | 1.5M | 8,238 | +0.56% |
| Q3 2017 | 2017-09-30 | 7.5M | 6.1M | +457.06% |
| Q2 2017 | 2017-06-30 | 7.5M | −3.2M | −30.05% |
| Q1 2017 | 2017-03-31 | 6.8M | −3.8M | −36.00% |
| Q4 2016 | 2016-12-31 | 1.5M | −6.2M | −80.78% |
| Q3 2016 | 2016-09-30 | 1.3M | −6.3M | −82.44% |
| Q2 2016 | 2016-06-30 | 10.7M | 3.1M | +40.38% |
| Q1 2016 | 2016-03-31 | 10.7M | 3.1M | +40.52% |
| Q4 2015 | 2015-12-31 | 7.7M | 3.5M | +85.55% |
| As of Nov 9, 2015 | 2015-11-09 | 7.6M | 4.1M | +117.41% |
| Q2 2015 | 2015-06-30 | 7.6M | 4.2M | +122.63% |
| Q1 2015 | 2015-03-31 | 7.6M | 4.2M | +123.00% |
| Q4 2014 | 2014-12-31 | 4.1M | 738,554.3 | +21.73% |
| Q3 2014 | 2014-09-30 | 3.5M | 114,109.6 | +3.36% |
| Q2 2014 | 2014-06-30 | 3.4M | 27,019.8 | +0.80% |
| Q1 2014 · Mar 31 | 2014-03-31 | 3.4M | 1.6M | +87.06% |
| Q4 2013 · Dec 31 | 2013-12-31 | 3.4M | 1.6M | +88.52% |
| Q1 2014 · Sep 30 | 2013-09-30 | 3.4M | 1.6M | +88.70% |
| Q4 2013 · Jun 30 | 2013-06-30 | 3.4M | −3.8M | −53.00% |
| Q3 2013 | 2013-03-31 | 1.8M | 105,557.025 | +6.16% |
| Q2 2013 · Dec 31 | 2012-12-31 | 1.8M | 98,663.975 | +5.79% |
| Q2 2013 · Dec 19 | 2012-12-19 | 1.8M | 95,526.35 | +5.60% |
| Q2 2013 · Dec 18 | 2012-12-18 | 7.2M | 5.5M | +323.00% |
| Q1 2013 | 2012-09-30 | 1.7M | 82,948.925 | +5.08% |
| Q4 2012 | 2012-06-30 | 1.7M | 99,375 | +6.19% |
| Q1 2012 | 2012-03-31 | 1.7M | 457,878.625 | +36.73% |
| Q4 2011 | 2011-12-31 | 1.7M | — | — |
| Q3 2011 | 2011-09-30 | 1.6M | — | — |
| Q2 2011 | 2011-06-30 | 1.6M | — | — |
| Q4 2010 | 2010-12-31 | 1.2M | — | — |
InspireMD shares outstanding trends
Over the last five reported fiscal years, InspireMD's shares outstanding moved from 3.3M to 43.5M, a change of 40.2M. The latest reported quarter, Q2 2026, shows 46.9M.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review InspireMD filings at SEC.gov ↗